FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133481605> ?p ?o ?g. }

• W2133481605 endingPage "6089" @default.
• W2133481605 startingPage "6077" @default.
• W2133481605 abstract "Conventional strategies of viral peptide immunizations often elicit low-affinity antibody responses and have limited ability to elicit immune responses in outbred animals of diverse major histocompatibility (MHC) haplotypes. This genetically restricted T-cell-stimulatory activity of peptides is a serious obstacle to vaccine design. However, the use of promiscuous T-cell epitopes may circumvent this problem. Promiscuous T-cell epitopes from tetanus toxin (amino acids [aa] 580 to 599) and the measles virus F protein (aa 288 to 302) that bind to several isotypic and allotypic forms of human MHC class II molecules have been identified and have been used in highly immunogenic constructs to overcome haplotype-restricted immune responses. Chimeric and beta-template peptide constructs incorporating known human T-lymphotropic virus type 1 (HTLV-1) B- and T-cell epitopes from the surface envelope protein gp46 (SP2 [aa 86 to 107] and SP4a [aa 190 to 209]) and promiscuous T-cell peptides were synthesized, and their immunogenicities were evaluated in both rabbits and mouse strains of divergent haplotypes (C3H/HeJ [H-2k], C57BL/6 [H-2b], and BALB/c [H-2d]). In addition, peptide preparations were structurally characterized by analytical high-performance liquid chromatography, mass spectrometry, and circular dichroism. In contrast to their linear forms, the chimeric constructs of both the SP2 and SP4a epitopes displayed alpha-helical secondary structures. Immunogenicity of the peptide constructs was evaluated by direct and competitive enzyme-linked immunosorbant assay (ELISA), as well as by radioimmunoprecipitation, syncytium inhibition, and antigen-induced lymphocyte proliferation assays. Immunization with the SP4a peptide without conjugation to a carrier protein produced antibodies specific for SP4a in two mouse strains (C3H/HeJ and C57BL/6). However, BALB/c mice failed to respond to the peptide, indicating that the T-cell epitope of the SP4a sequence is MHC restricted. In contrast, the chimeric constructs MVF-SP2 and SP4a-measles virus F protein were highly immunogenic, producing elevated ELISA titers after only two immunizations. Elicited antibodies recognized native forms of gp46 in ELISAs and radioimmunoprecipitation assays, as well as inhibited HTLV-1-mediated syncytium formation. In addition, chimeric constructs were effective at induction of lymphocyte proliferation to the T-cell epitope, SP4a, in each strain of immunized mice. Our data demonstrate that the antibody response to retroviral peptides is enhanced by promiscuous peptide constructs, in part because of the ability of such constructs to promote appropriate secondary structural forms of viral epitopes. In addition, these constructs promote virus-specific helper T-cell responses, thereby overcoming genetically restricted immune responses to the synthetic peptides." @default.
• W2133481605 created "2016-06-24" @default.
• W2133481605 creator A5017826930 @default.
• W2133481605 creator A5037199242 @default.
• W2133481605 creator A5047127426 @default.
• W2133481605 creator A5072377159 @default.
• W2133481605 creator A5078184468 @default.
• W2133481605 creator A5087317845 @default.
• W2133481605 date "1995-10-01" @default.
• W2133481605 modified "2023-10-15" @default.
• W2133481605 title "Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction" @default.
• W2133481605 cites W1495379793 @default.
• W2133481605 cites W1521518192 @default.
• W2133481605 cites W1532205945 @default.
• W2133481605 cites W1542067597 @default.
• W2133481605 cites W1579042999 @default.
• W2133481605 cites W1585892244 @default.
• W2133481605 cites W1589591642 @default.
• W2133481605 cites W1591641721 @default.
• W2133481605 cites W1658245484 @default.
• W2133481605 cites W1837983658 @default.
• W2133481605 cites W1886710724 @default.
• W2133481605 cites W1898074412 @default.
• W2133481605 cites W1919237496 @default.
• W2133481605 cites W1928975248 @default.
• W2133481605 cites W1929787528 @default.
• W2133481605 cites W1938054245 @default.
• W2133481605 cites W1944727474 @default.
• W2133481605 cites W1966369885 @default.
• W2133481605 cites W1967865769 @default.
• W2133481605 cites W1972942325 @default.
• W2133481605 cites W1976232165 @default.
• W2133481605 cites W1989106621 @default.
• W2133481605 cites W1989452309 @default.
• W2133481605 cites W1991941671 @default.
• W2133481605 cites W2003236386 @default.
• W2133481605 cites W2011851534 @default.
• W2133481605 cites W2018547049 @default.
• W2133481605 cites W2026719190 @default.
• W2133481605 cites W2033072453 @default.
• W2133481605 cites W2035194338 @default.
• W2133481605 cites W2044063726 @default.
• W2133481605 cites W2046182783 @default.
• W2133481605 cites W2057297514 @default.
• W2133481605 cites W2058071227 @default.
• W2133481605 cites W2061946989 @default.
• W2133481605 cites W2064811345 @default.
• W2133481605 cites W2069667541 @default.
• W2133481605 cites W2071254676 @default.
• W2133481605 cites W2080979551 @default.
• W2133481605 cites W2086511733 @default.
• W2133481605 cites W2086730891 @default.
• W2133481605 cites W2106396076 @default.
• W2133481605 cites W2111441225 @default.
• W2133481605 cites W2150756957 @default.
• W2133481605 cites W2154802031 @default.
• W2133481605 cites W2156740669 @default.
• W2133481605 cites W2167174534 @default.
• W2133481605 cites W2336211911 @default.
• W2133481605 cites W2404490605 @default.
• W2133481605 doi "https://doi.org/10.1128/jvi.69.10.6077-6089.1995" @default.
• W2133481605 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/189504" @default.
• W2133481605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7545241" @default.
• W2133481605 hasPublicationYear "1995" @default.
• W2133481605 type Work @default.
• W2133481605 sameAs 2133481605 @default.
• W2133481605 citedByCount "68" @default.
• W2133481605 countsByYear W21334816052012 @default.
• W2133481605 countsByYear W21334816052013 @default.
• W2133481605 countsByYear W21334816052014 @default.
• W2133481605 countsByYear W21334816052016 @default.
• W2133481605 countsByYear W21334816052018 @default.
• W2133481605 countsByYear W21334816052019 @default.
• W2133481605 countsByYear W21334816052020 @default.
• W2133481605 countsByYear W21334816052021 @default.
• W2133481605 countsByYear W21334816052022 @default.
• W2133481605 countsByYear W21334816052023 @default.
• W2133481605 crossrefType "journal-article" @default.
• W2133481605 hasAuthorship W2133481605A5017826930 @default.
• W2133481605 hasAuthorship W2133481605A5037199242 @default.
• W2133481605 hasAuthorship W2133481605A5047127426 @default.
• W2133481605 hasAuthorship W2133481605A5072377159 @default.
• W2133481605 hasAuthorship W2133481605A5078184468 @default.
• W2133481605 hasAuthorship W2133481605A5087317845 @default.
• W2133481605 hasBestOaLocation W21334816051 @default.
• W2133481605 hasConcept C147483822 @default.
• W2133481605 hasConcept C153911025 @default.
• W2133481605 hasConcept C159047783 @default.
• W2133481605 hasConcept C195616568 @default.
• W2133481605 hasConcept C207936829 @default.
• W2133481605 hasConcept C2776090121 @default.
• W2133481605 hasConcept C2779281246 @default.
• W2133481605 hasConcept C2780868878 @default.
• W2133481605 hasConcept C54355233 @default.
• W2133481605 hasConcept C55493867 @default.
• W2133481605 hasConcept C86803240 @default.
• W2133481605 hasConcept C8891405 @default.
• W2133481605 hasConceptScore W2133481605C147483822 @default.

• next